These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10493460)

  • 41. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In the dark: the reporting of blinding status in randomized controlled trials.
    Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
    J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current and future challenges in the design and analysis of cluster randomization trials.
    Klar N; Donner A
    Stat Med; 2001 Dec; 20(24):3729-40. PubMed ID: 11782029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.
    Hannan EL
    JACC Cardiovasc Interv; 2008 Jun; 1(3):211-7. PubMed ID: 19463302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions.
    Villar J; Carroli G
    Prev Med; 1996; 25(3):365-75. PubMed ID: 8781015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
    Hammad TA; Pinheiro SP; Neyarapally GA
    Clin Trials; 2011 Oct; 8(5):559-70. PubMed ID: 21878445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial of epidural injections for spinal stenosis published in the New England Journal of Medicine: further confusion without clarification.
    Manchikanti L; Candido KD; Kaye AD; Boswell MV; Benyamin RM; Falco FJ; Gharibo CG; Hirsch JA
    Pain Physician; 2014; 17(4):E475-88. PubMed ID: 25054398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. External validity: we need to do more.
    Glasgow RE; Green LW; Klesges LM; Abrams DB; Fisher EB; Goldstein MG; Hayman LL; Ockene JK; Orleans CT
    Ann Behav Med; 2006 Apr; 31(2):105-8. PubMed ID: 16542124
    [No Abstract]   [Full Text] [Related]  

  • 50. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
    Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
    Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management and conduct of randomized controlled trials.
    Knatterud GL
    Epidemiol Rev; 2002; 24(1):12-25. PubMed ID: 12119852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized controlled trials: methodological concepts and critique.
    Salmond SS
    Orthop Nurs; 2008; 27(2):116-22; quiz 123-4. PubMed ID: 18385595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In search of justification for the unpredictability paradox.
    Howick J; Mebius A
    Trials; 2014 Dec; 15():480. PubMed ID: 25490908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reliability and validity in research.
    Roberts P; Priest H
    Nurs Stand; 2006 Jul 12-18; 20(44):41-5. PubMed ID: 16872117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging standards in statistical practice: implications for clinical trials in rehabilitation medicine.
    Millis SR
    Am J Phys Med Rehabil; 2003 Oct; 82(10 Suppl):S32-7. PubMed ID: 14502037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What is right and what is wrong about evidence-based medicine?
    Julian DG
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S2-5. PubMed ID: 12950509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methodological issues in observational studies and non-randomized controlled trials in oncology in the era of big data.
    Tanaka S; Tanaka S; Kawakami K
    Jpn J Clin Oncol; 2015 Apr; 45(4):323-7. PubMed ID: 25589456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.
    Braido F; Baiardini I; Compalati E; Bordo A; Canonica GW
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):361-74. PubMed ID: 21659859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical trials in rehabilitation: what are the obstacles?
    Whyte J
    Am J Phys Med Rehabil; 2003 Oct; 82(10 Suppl):S16-21. PubMed ID: 14502034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.